Rhelion Life Sciences Corp. ( TRUFF) - Stock Earnings
TRUFF Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2022Q1 | -7.9 million CAD | 622467 CAD |
| 2022Q2 | -1.5 million USD | 785086 USD |
| 2022Q3 | -1.3 million USD | 736428 USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
TRUFF Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2021 | -1.6 million CAD | 110956 CAD |
| 2022 | -14.4 million USD | 2.3 million USD |
| 2027 Est. | — | — |
TRUFF
Price: $0.02
52 week price:
Earnings Per Share: -0.01 USD
P/E Ratio: -1.20
Exchange: OQB
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 7.8 million